As of July 2026, 88 paid clinical trials are recruiting in Maplewood, Minnesota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Maplewood offers studies at sites including Saint John's Hospital - Healtheast for conditions such as Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Maplewood, MN at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint John's Hospital - Healtheast | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 55 |
| Minnesota Oncology Hematology PA-Maplewood | Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8 | 49 |
| M Health Fairview St. John's Hospital | Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 6 |
| Minnesota Oncology Hematology, P.A. | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 4 |
| Fairview Health Services | Acute Myocardial Infarction (AMI), Atrial Fibrillation (AF), Cardiovascular Risk | 2 |
| Fairview Health Services M Health Fairview St Johns Hospital | Obesity, Atherosclerotic Cardiovascular Disease, Heart Failure With Mildly Reduced Ejection Fraction | 2 |
| Minnesota Oncology Hematology, PA | Colorectal Neoplasms, Triple Negative Breast Cancer | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Fairview Health | Heart Failure | 1 |
| Headlands Research-Twin Cities | Obesity, Overweight, Sleep Apnea, Obstructive | 1 |
| Health East Cancer Care | Cardiovascular Disease | 1 |
| M Health Fairview St. John's | Acute Infection, Organ Failure, Sepsis | 1 |
| Minnesota Oncology Hematology PA | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Site 0288 - Minnesota Oncology Hematology - Maplewood | High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer | 1 |
| St. John's | Acute Infection, Organ Failure, Sepsis | 1 |
| Twin Cities Surg Ctr Maplewood | Lumbar Spinal Stenosis | 1 |
| USOR - Minnesota Oncology-Maplewood Clinic | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| USOR - Minnesota Oncology/ Maplewood Clinic | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| USOR Minnesota Oncology Hematology | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 1 |
Recruiting trials in Maplewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 88 recruiting clinical trials in Maplewood, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Maplewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Maplewood include Malignant Solid Neoplasm (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Anatomic Stage IV Breast Cancer AJCC v8 (3), Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Maplewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Maplewood include Saint John's Hospital - Healtheast, Minnesota Oncology Hematology PA-Maplewood, M Health Fairview St. John's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Maplewood are Cancer & tumors (65), Diabetes & metabolic (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.